Indra

Indra

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

66/100MonitorFreeFree

INDRA earns its place if you are a computational biologist who needs an auditable path from literature and databases to an executable model. Nothing else open-source covers the same reader breadth (REACH, TRIPS/DRUM, Sparser, Eidos, TEES, MedScan and more), puts a knowledge-level assembly step in the middle, and lands in PySB, SBML, BNGL, Kappa, SBGN and BEL on the other side. If you want one-click pathway analysis in a GUI, you are looking at the wrong tool. Budget scripting time and local CPU; INDRA is infrastructure, not an app.

Verified 18h ago · liveness 66/100 · cite: rightaichoice.com/tools/indra

Best for
  • Systems biologists building executable mechanistic models
  • Bioinformaticians needing reproducible, auditable assembly pipelines
  • Computational pharmacologists integrating drug-target evidence
  • Teams using PySB for rule-based modeling and simulation
Not ideal for
  • Non-programmers who need a GUI and out-of-the-box modeling
  • Biologists wanting one-click pathway analysis without pipeline development
  • Users who need a commercial support contract or enterprise SLA
Visit Website

AdvancedFor a Python-comfortable bioinformatician, a first assembled Statement set from one reader plus one database is typically a single working session; a full multi-reader, multi-database pipeline with Preassembler and PySB export takes longer, mostly in installing and configuring individual reader and database modules. Non-programmers should expect substantially more.API · CLIAPI availableVerified 18h ago
Pricing
Free
FreeFree tier4 hidden costs
Learning curve
Advanced
For a Python-comfortable bioinformatician, a first assembled Statement set from one reader plus one database is typically a single working session; a full multi-reader, multi-database pipeline with Preassembler and PySB export takes longer, mostly in installing and configuring individual reader and database modules. Non-programmers should expect substantially more.
Runs on
APICLI
API available · 16 integrations
Who it's for
Systems biologist with a Python backgroundComputational pharmacologist assembling drug-target evidenceBioinformatician supporting a wet-lab group
Live sentiment
Is Indra actually worth it?

We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.

  • Honest verdict, not marketing
  • Real pros & cons from real users
  • Attributed quotes with receipts
Run a free scan

3 free scans · no card needed

Skip it if

Skip INDRA if you want to upload a gene list and get a pathway diagram back from a browser — INDRA is a Python library with no graphical interface, so you need to script the assembly pipeline yourself.

The 30-second take
Biggest gripe

Assembly of large literature corpora is CPU-heavy: the software is MIT-licensed, but the compute bill for reading thousands of papers lands on your own infrastructure or cloud account.

Price reality

INDRA is MIT-licensed open source at no cost, so the comparison is not licence fee versus licence fee but total cost of ownership: you trade the subscription price of a commercial pathway suite for scripting time, local CPU and curation effort. For a funded academic lab with a Python-capable bioinformatician that trade is usually favourable; for a small team without programming capacity it is not.

In short

Indra — Open-source Python framework that assembles causal and mechanistic models from literature and biological databases. Best for Systems biologists building executable mechanistic models, Bioinformaticians needing reproducible, auditable assembly pipelines, Computational pharmacologists integrating drug-target evidence. Free to use.

What people actually say about Indra — is it worth it?

We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.

48 mentions across 5 sources (Hacker News, YouTube, Product Hunt, GitHub, Lemmy) · researched Aug 4, 2026.

47% positive53% critical

Average across the 5 sources that answered — each source counts once, not each post.

Recurring strengths
  • +Integrates 12+ NLP readers and 20+ databases into one standard format.
  • +Knowledge-level assembly resolves contradictions and filters by reliability.
  • +Exports to SBML, BNGL, SBGN, Graphviz, and human-readable summaries.
  • +Free, MIT-licensed, with full transparency versus commercial alternatives.
  • +REST API and Docker support simplify remote and reproducible deployments.
Recurring frustrations
  • −Steep learning curve — requires programming and systems biology expertise.
  • −No GUI; everything is command-line and Python-based.
  • −Documentation is extensive but could be overwhelming for newcomers.
  • −Setup can be complicated due to many dependencies and integrations.
  • −Community support is sparse — few forums or success stories.
Patterns worth knowing
Technical power and transparency are highly valued by expert users
Seen on Hacker News, GitHub
The steep learning curve is the #1 barrier to adoption
Seen on Hacker News, Lemmy, GitHub
Compared to commercial tools, Indra lacks polish but offers freedom and no lock-in
Seen on Hacker News
Learning curve
advancedProductive in ~Days of setup
Hidden costs people mention
  • • Time spent learning Python and bioinformatics concepts
  • • Potential cost of hiring a specialist to operate the tool
  • • Custom integrations may require development effort

Viability Score

66/100
Monitor

How well maintained and how widely used is Indra? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this

Recent activity
not measured
Traction
100
Site health
95
User sentiment
47
What the vendor publishes
20

Last calculated: October 2026

How we score →

Key Features

  • Integration with NLP reading systems (REACH, TRIPS/DRUM, Sparser, Eidos, TEES, MedScan)
  • Additional readers including RLIMS-P, ISI/AMR, Geneways, GNBR, SemRep, textToKnowledgeGraph
  • Biological database importers (PathwayCommons/BioPAX, BioGRID, Signor, DrugBank, OmniPath)
  • Further database sources: HPRD, TRRUST, Phospho.ELM, VirHostNet, CTD, DGI, CRoG, CREEDS, UbiBrowser, ACSN, WormBase
  • Target Affinity Spectrum (TAS) importer for drug-target evidence
  • Custom knowledge base inputs (NDEx/CX, INDRA DB, Hypothes.is, Biofactoid, MINERVA)
  • Standardized INDRA Statements representation across all sources
  • Knowledge-level assembly: error correction, redundancy resolution, inference, scope filtering
  • Preassembler for resolving redundancy and contradiction between sources
  • BeliefEngine for confidence scoring of causal assertions
  • PySB assembler producing executable rule-based models via a policy-guided assembly procedure
  • Compilation of PySB models to SBML, SBGN, BNGL, and Kappa
  • PyBEL, IndraNet, SIF and KAMI assemblers for causal analysis and Kappa modeling
  • Visualization outputs: Graphviz, Cytoscape JS, SBGN, CX, SIF
  • Curation outputs: HTML, TSV, IndexCards

About Indra

FreeAdvancedAPI availableAPI · CLI

INDRA (Integrated Network and Dynamical Reasoning Assembler) is an open-source Python system that pulls mechanistic and causal assertions out of natural language processing readers and structured biological databases, converts each source's output into a standardized INDRA Statement, then runs knowledge-level assembly: correcting systematic input errors, resolving redundancy, inferring missing information, filtering to a scope you specify, and scoring the reliability of each causal claim. On the reader side it wraps TRIPS/DRUM, REACH, Sparser, Eidos, TEES, MedScan, RLIMS-P, ISI/AMR, Geneways, GNBR, SemRep and textToKnowledgeGraph; on the database side PathwayCommons/BioPAX, BEL, Signor, BioGRID, Target Affinity Spectrum, HPRD, TRRUST, Phospho.ELM, VirHostNet, CTD, DrugBank, OmniPath, DGI, CRoG, CREEDS, UbiBrowser, ACSN and WormBase, plus custom knowledge bases via NDEx/CX, the INDRA DB REST service, Hypothes.is, Biofactoid and MINERVA. Output assemblers take those Statements to a PySB rule-based executable model (compiling onward to SBML, SBGN, BNGL and Kappa), to causal graphs through PyBEL, IndraNet, SIF and KAMI, to visualizations in Graphviz, Cytoscape JS, CX, SBGN and SIF, to curation artifacts in HTML, TSV and IndexCards, and to plain-English summaries via the English Assembler. External assemblers such as Delphi (Dynamic Bayesian Networks) and CauseMos can plug into the same Statement stream. It is built for systems biologists, bioinformaticians and computational pharmacologists who need a reproducible, auditable assembly pipeline and are willing to script in Python — there is no graphical interface.

Behind the Verdict

The thing that separates INDRA from a pile of NLP scripts is the middle layer. Anyone can call REACH or Sparser on a PubMed dump; INDRA's contribution is the standardized Statement plus the Preassembler and BeliefEngine that sit between extraction and model. That is where systematic reader errors get corrected, where the same interaction reported by four sources gets collapsed instead of quadruplicated, and where you get a confidence score before committing an edge to a model. If your review process needs to explain why a causal edge exists, this is the architecture you want. The output range is the second reason to pick it. The PySB assembler is described in the vendor's own material as the most sophisticated model assembler, and it implements a policy-guided automated assembly procedure whose result compiles onward to SBML, Kappa, BNGL and SBGN — so a model built here reaches the wider simulation ecosystem rather than dead-ending in a proprietary format. For graph work you get PyBEL, IndraNet, SIF and KAMI; for showing colleagues what you found you get Cytoscape JS, Graphviz, CX and SBGN, and for getting a domain expert to sign off you get HTML, TSV and IndexCards curation artifacts. Where it hurts: you drive it from Python or Docker, and the scraped material shows no GUI at all, so a wet-lab collaborator cannot pick it up without you. Large-corpus assembly is computationally intensive — real CPU time, not a laptop-afternoon job. Several readers and databases are external community services, so pipeline reliability partly depends on infrastructure you do not control, and extraction quality upstream propagates downstream unless you use the Preassembler and BeliefEngine and curate. INDRA World shows the assembly pattern generalizes beyond molecular biology, which is worth knowing if your causal-graph problem is not biological at all.

Researching Indra? Get your full AI stack in 60 seconds.

Free, no signup — tell us your goal and get tools matched to your budget & existing stack.

Real-world workflow fit

Concrete scenarios for the personas Indra actually fits — and what changes day-one when you adopt it.

Systems biologist with a Python background

You have a list of signalling proteins from a perturbation experiment and need a mechanistic model you can simulate. You run REACH and Sparser over the relevant PubMed subset, pull BioGRID and Signor through their importers, run the Preassembler to collapse redundant edges, filter with the BeliefEngine, then hand the Statements to the PySB assembler and compile to SBML.

Outcome: A rule-based executable model with a traceable evidence trail back to the sources that produced each interaction, rather than a hand-curated diagram with no provenance.

Computational pharmacologist assembling drug-target evidence

You want causal hypotheses linking a drug to downstream pathway effects. You import DrugBank and Target Affinity Spectrum alongside OmniPath and CTD, assemble the combined Statement set, and score assertions so weak literature-only edges do not outrank experimentally supported ones.

Outcome: A ranked causal graph you can defend in a review meeting, with low-confidence edges visibly separated from high-confidence ones.

Bioinformatician supporting a wet-lab group

A colleague asks what the literature says about a specific regulatory interaction. You assemble the Statements and run the English Assembler plus the HTML or IndexCards exporter so the expert can read and correct the claims directly.

Outcome: A curation artifact the biologist can review without touching Python, and corrections that feed back into the assembled model.

Use Cases

Limitations

  • INDRA is a Python library: you install it locally or run it via Docker, and you drive it from code — the scraped material shows no graphical interface.
  • Assembly of large corpora is computationally intensive, so plan for real CPU and time.
  • Several readers and databases are external community services (for example REACH, Eidos, and MedScan), so pipeline reliability partly depends on infrastructure you do not control.
  • Output quality is bounded by the underlying readers: inaccurate extractions propagate into assembled statements unless you use the Preassembler and BeliefEngine and curate the results.
  • Biological coverage is also uneven across the twenty-odd database importers — a pathway only in an unimported resource will not appear.

as of 2026-10-18

Verification history

We have re-verified Indra 8 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.

  1. — re-checked, vendor evidence unchanged
  2. — re-checked, vendor evidence unchanged
  3. — re-checked, vendor evidence unchanged
  4. — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
  5. — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
  6. — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it

Showing the 6 most recent of 8 verification passes.

Free to cite with attribution — this page re-verifies continuously.

12-month cost

Project the real annual outlay, including the implied monthly cost when only an annual tier is published.

Annual total
Free
Over 12 months
Effective monthly
—
—

Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.

Plans compared

For each published Indra tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.

Open Source

$0

Ideal for

Academic labs and computational biology groups with in-house Python capacity who need auditable model assembly and are comfortable running their own compute.

What this tier adds

Starting (and only) tier: MIT-licensed access to all INDRA modules, the REST API, Docker deployment, and community support via GitHub at no cost.

Hidden costs & gotchas

What the public pricing page doesn't put in bold. Captured from pricing-page footnotes, contract terms, and recurring complaints.

  • Assembly of large literature corpora is CPU-heavy: the software is MIT-licensed, but the compute bill for reading thousands of papers lands on your own infrastructure or cloud account.
  • Several readers and databases (REACH, Eidos, MedScan, and the online INDRA DB) are external community-run services, so when one is slow or down your pipeline stalls and you absorb the retry and maintenance effort.
  • Raw reader output carries systematic errors, so the real cost is curation labour: without running the Preassembler and BeliefEngine and having a domain expert review the HTML, TSV or IndexCards artifacts, bad
  • Compiling PySB models onward to SBML, BNGL or Kappa pulls in a second toolchain to install, version-pin and maintain alongside INDRA itself.

Where the pricing makes sense

The company stage and team size where Indra's pricing actually pencils out — and where peers do it cheaper.

INDRA is MIT-licensed open source at no cost, so the comparison is not licence fee versus licence fee but total cost of ownership: you trade the subscription price of a commercial pathway suite for scripting time, local CPU and curation effort. For a funded academic lab with a Python-capable bioinformatician that trade is usually favourable; for a small team without programming capacity it is not.

Setup time & first value

How long it actually takes to get something useful out of Indra — broken out by persona, not the marketing-page minute.

For a Python-comfortable bioinformatician, a first assembled Statement set from one reader plus one database is typically a single working session; a full multi-reader, multi-database pipeline with Preassembler and PySB export takes longer, mostly in installing and configuring individual reader and database modules. Non-programmers should expect substantially more.

Switching to or from Indra

How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.

Migrating in
  • →From a hand-curated pathway diagram: Export or re-import the underlying interactions through the NDEx/CX or BEL importers so existing curation becomes Statements rather than starting from scratch.
  • →From a single NLP reader: Keep that reader's module (REACH, Sparser or TEES) and add the Preassembler plus BeliefEngine to gain redundancy resolution and confidence scoring across additional sources.
  • →From PyBEL-only workflows: PyBEL is one of INDRA's own assemblers, so existing BEL content and analysis steps carry forward while you gain the PySB and database-import paths.
Migrating out
  • ↗To a simulation environment: Compile the PySB model onward to SBML, BNGL or Kappa and open it in the corresponding simulation toolchain.
  • ↗To a network analysis tool: Export SIF, CX or SBGN and load the graph into Cytoscape or another network tool for downstream analysis and figure production.
  • ↗To a commercial pathway suite: Export Statements as SIF or TSV and re-import edges into the commercial tool for teams that need a GUI for the final analysis step.

Integrations

REACHTRIPS/DRUMSparserEidosTEESMedScanRLIMS-PISI/AMRGenewaysGNBRSemRepPathwayCommonsBioGRIDSignorDrugBankOmniPath

Resources & Guides

Tutorials & Learning

YouTube returned 6 videos for “Indra”, and we withheld 6: 6 could not be judged, because “Indra” is a single word that other videos use for other things. We are showing none, because we could not prove any of them are about Indra.

Official links

Tools that pair well with Indra

Common stack mates teams adopt alongside Indra, with the specific reason each pairing earns its keep.

Featured Head-to-Head Comparisons

Alternatives to Indra

View all
CUREBench

CUREBench

CURE-Bench is an open-source benchmark grading AI therapeutic decision-making and software-engineering reasoning at scale.

FreeTry
DrugClaw

DrugClaw

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

FreeTry
Recursion

Recursion

Recursion OS pairs automated wet labs with AI models for AI drug discovery at up to 2 million weekly experiments.

Contact SalesTry

Frequently Asked Questions

Used Indra? Help shape our editorial sentiment research.